Article Information
PubMed
Published By
Online ISSN
History
- Published online June 27, 2017.
Copyright & Usage
© Barnhart. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly cited. To view a copy of the license, visit http://creativecommons.org/licenses/by/3.0/. When linking to this article, please use the following permanent link: https://doi.org/10.9745/GHSP-D-17-00206
Author Information
- Matthew Barnharta⇑
- aAssociate Editor, Global Health: Science and Practice, and Medical Officer, U.S. Agency for International Development, Washington, DC, USA.
- Correspondence to Matthew Barnhart (mbarnhart{at}ghspjournal.org).
Statistics from Altmetric.com
Article usage
Cited By...
In this issue
Statistics from Altmetric.com
Jump to section
- Article
- WHY WE NEED LONG-ACTING ANTIRETROVIRALS
- TANGIBLE PROGRESS ON A 1- OR 2-MONTH INJECTABLE
- NEW ARVS MAY HELP OVERCOME THESE DOWNSIDES
- BROADLY NEUTRALIZING ANTIBODIES: A POSSIBLE ALTERNATIVE TO LONG-ACTING ARVS FOR PREVENTION
- IMPLANTS THAT ARE EASIER TO IMPLEMENT: BIODEGRADABLE AND REFILLABLE APPROACHES
- IMPROVED INJECTION APPROACHES: SIMPLIFYING ADMINISTRATION, REDUCING COST AND DISCOMFORT
- COLLABORATIVE EFFORTS TO ADVANCE NEW ARVS
- CONTINUING DOWN THE ROAD TO ULTIMATE SUCCESS
- Acknowledgments
- Notes
- REFERENCES
- Figures & Tables
- Info & Metrics
- Comments
Related Articles
Cited By...
- No citing articles found.